Literature DB >> 7127665

Daunorubicin-DNA complex in acute nonlymphoblastic leukemia.

R Hulhoven, C Harvengt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127665     DOI: 10.1007/bf00254059

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  6 in total

1.  HPLC determination of daunorubicin and daunorubicinol in human plasma.

Authors:  R Hulhoven; J P Desager
Journal:  Biomedicine       Date:  1977-04

2.  Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.

Authors:  C Paul; M Björkholm; I Christenson; L Engstedt; G Gahrton; R Hast; G Holm; A Killander; B Lantz; D Lockner; B Lönnqvist; H Mellstedt; J Palmblad; C Peterson; B Simonsson; A M Stalfelt; A M Udén; B Wadman; G Oberg
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Human pharmacokinetics of the daunorubicin-DNA complex. An alternative view of the lysosomotropic theory.

Authors:  R Hulhoven; G Sokal; C Harvengt
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubicin-DNA complex in the rabbit. II. -- Effects of R. E. S.-blockade.

Authors:  R Hulhoven; C Haravengt
Journal:  Biomedicine       Date:  1980-04

5.  Distribution of daunorubicin intravenously injected or intravenously infused as free drug and as a complex with DNA in rabbits.

Authors:  R Hulhoven; C Harvengt
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

6.  Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubican-DNA complex in the rabbit.

Authors:  R Hulhoven
Journal:  Biomedicine       Date:  1978-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.